Status:
COMPLETED
Zinc Supplementation in Shigella Patients
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Testing Effect of Intervention
Eligibility:
All Genders
12-59 years
Phase:
PHASE3
Brief Summary
Shigellosis is a major cause of morbidity and mortality in young children in Bangladesh and other developing countries. Further, the increasing emergence of resistance to a wide range of antibiotics i...
Detailed Description
Study design: The study was a double blind randomised clinical trial using zinc and placebo using multivitamin base.Study subjects: Fifty six children of both sex aged between 12-59 months were studie...
Eligibility Criteria
Inclusion
- Age between 12-59 months
- Moderate malnutrition (61-75% Weight / Age - NCHS Median)
- Duration of diarrhoea of 5 days
- Culture confirmed shigella spp in stool on enrolment
Exclusion
- Measles infection in the past six months
- Presence of obvious systemic illnesses
- Severe malnutrition
- Residence in a location requiring a journey of\>2 hour from the Dhaka Hospital of the ICDDR,B
- Refusal to give consent
Key Trial Info
Start Date :
January 1 1999
Trial Type :
INTERVENTIONAL
End Date :
April 1 2002
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00321126
Start Date
January 1 1999
End Date
April 1 2002
Last Update
May 3 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.